Hyperbaric oxygen therapy could “significantly affect the expression levels of IL-12p40, MIP-1β, PDGF-BB, and IL-1Ra, indicating that the effects of HBO therapy are associated with the attenuation of inflammatory responses”. <view study> Read Less

All participants in this study were diagnosed with persistent post concussion syndrome related to mild traumatic brain injury. A randomized group received a full course of 40 hyperbaric treatments at 1.5 ATA, daly for 60 minutes, 5 consecutive days per week, for a total of 8 weeks (2 month long hyperbaric intervention). The hyperbaric subjects experienced significant improvements in memory, anxiety, sleep, PTSD symptoms, and quality of life. More importantly, After crossing over to HBOT the Control Group experienced near-identical significant improvements. Further improvements were experienced by both groups after completion of their last hyperbaric session, during the 2-month follow-up period.” <view study> Read Less

Alterations in social behavior, including but not limited to anxiety, are prominent features of Fragile X syndrome (FXS). The findings of this study indicate that hyperbaric oxygen therapy “resulted in altered anxiety and social behavior in mice (showing increased levels of social interaction and decreased "social anxiety”) and could possibly be used as a treatment for FXS” <view study> Read Less

The results suggest that preconditioning with hyperbaric oxygen therapy can attenuate peripheral neuropathy caused by cisplatin in rats <view study> Read Less

A prospective observational study was conducted on 10 patients with lymphedema (breast cancer related — BCRL). Bioimpedance spectroscopy (a relatively new diagnostic tool for evaluating the severity of the lymphedema) confirmed the benefits of Hyperbaric oxygen therapy alongside conventional therapy <view study> Read Less